Deng, T., Ba, Y., Bai, M., Gong, Z., Liu, C., Zhang, F., Xu, Q., Yi, B., Xiang, X., Bai, J., Liu, H., Wang, G., Wang, Z., Liu, Z., Jiang, Y., Chen, H., Huang, F., Wang, X. (2025). Continuation of serplulimab-based therapy beyond first progression in advanced gastric/gastroesophageal junction (G/GEJ) cancer: Preliminary results from the SCAFIGC trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e16022